Search

everythinglearnresearchcommunity

for

Search:↓

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Anabolic steroid users may face higher risk of severe COVID-19.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Hair gets thinner, grayer, and changes texture with age due to genetics, environment, and cellular changes, affecting the growth cycle.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Moderately high prolactin levels do not cause hair loss in women.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Hair gets thinner and grayer with age, and density decreases more in men on top and in women on top and back.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.